Ann: SIRFLOX Awarded Oral Presentation at ASCO, page-26

First 26 Last

Share
Profile

Follow
wild-1

1,255 Posts.

12

11/05/15

22:32

Post #: 15258722
Share

Originally posted by plasticd ↑

Hi cafa

I am pretty sure LBA signifies a late submission of an abstract when preliminary data not available

From the website
The ASCO late-breaking data policy allows for the submission of late-breaking data only for randomized phase II and III trials for which no preliminary data are available at the time of the abstract submission deadline (February 3, 2015), but for which a preplanned analysis of the primary endpoint is scheduled after that date but before April 1, 2015 (the deadline for the final, updated late-breaking data). During abstract submission, you will be required to provide the primary clinical endpoint for analysis, type of analysis, date of planned analysis, and planned statistical methods for analysis. The policy is not a mechanism to allow for updated data to be submitted later when preliminary data are available by the abstract submission deadline.

My understanding is this is not the case for this trial in that the data was available at the time of abstract submission. LBA allows for presenters to submit an abstract when all the data hasn't been analysed yet but will be by April 1st.

I could be wrong but I don't believe this the case for this trial so we should expect this abstract to be published in a few days.

D

Expand

Preliminary data regarding primary endpoint for SIRFLOX was available in March. I may be wrong, but I suspect that makes this considered late breaking

SRX Price at posting: $19.05 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

IMU

Imugene kicks off Australian trial for blood cancer treatment

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

HotCopper Highlights: Your most watched and most discussed stocks this week

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Trump is President Again: What Does This Mean for Crypto?